CC-90011
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CC-90011, covering 2024-08-26 to 2025-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas [Phase 1]